Pluri Inc. (NASDAQ:PLUR – Get Free Report)’s stock price dropped 4.4% during trading on Tuesday . The company traded as low as $4.30 and last traded at $4.30. Approximately 28,199 shares traded hands during mid-day trading, an increase of 89% from the average daily volume of 14,909 shares. The stock had previously closed at $4.50.
Pluri Stock Down 4.4 %
The stock has a market cap of $23.90 million, a price-to-earnings ratio of -0.71 and a beta of 1.67. The firm’s fifty day moving average price is $4.62 and its two-hundred day moving average price is $5.02. The company has a debt-to-equity ratio of 4.44, a current ratio of 5.90 and a quick ratio of 5.90.
Pluri (NASDAQ:PLUR – Get Free Report) last issued its earnings results on Tuesday, November 12th. The company reported ($1.08) earnings per share (EPS) for the quarter. The firm had revenue of $0.33 million during the quarter. Pluri had a negative return on equity of 917.18% and a negative net margin of 4,184.28%.
About Pluri
Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.
Recommended Stories
- Five stocks we like better than Pluri
- The Basics of Support and Resistance
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- Earnings Per Share Calculator: How to Calculate EPS
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Best Stocks Under $10.00
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Pluri Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pluri and related companies with MarketBeat.com's FREE daily email newsletter.
